These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7492179

  • 21. Superantigens in dermatology.
    Macias ES, Pereira FA, Rietkerk W, Safai B.
    J Am Acad Dermatol; 2011 Mar; 64(3):455-72; quiz 473-4. PubMed ID: 21315950
    [Abstract] [Full Text] [Related]

  • 22. A case of guttate psoriasis following Kawasaki disease.
    Han MH, Jang KA, Sung KJ, Moon KC, Koh JK, Choi JH.
    Br J Dermatol; 2000 Mar; 142(3):548-50. PubMed ID: 10735970
    [Abstract] [Full Text] [Related]

  • 23. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
    Gupta-Malhotra M, Viteri-Jackson A, Thomas W, Zabriskie JB.
    Exp Mol Pathol; 2004 Apr; 76(2):117-21. PubMed ID: 15010289
    [Abstract] [Full Text] [Related]

  • 24. Superantigens in the aetiology of Kawasaki disease.
    Fischer P, Uttenreuther-Fischer MM, Gaedicke G.
    Lancet; 1996 Jul 20; 348(9021):202. PubMed ID: 8684184
    [No Abstract] [Full Text] [Related]

  • 25. Superantigens and their role in infectious disease.
    Schafer R, Sheil JM.
    Adv Pediatr Infect Dis; 1995 Jul 20; 10():369-90. PubMed ID: 7718212
    [Abstract] [Full Text] [Related]

  • 26. Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease.
    Yoshioka T, Matsutani T, Toyosaki-Maeda T, Suzuki H, Uemura S, Suzuki R, Koike M, Hinuma Y.
    Pediatr Res; 2003 Mar 20; 53(3):403-10. PubMed ID: 12595587
    [Abstract] [Full Text] [Related]

  • 27. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM, Schaffer FM, Myones BL, Yount WJ, Rowe RD, Rubin L, Stein LD, Gelfand EW, Silverman ED.
    Prog Clin Biol Res; 1987 Mar 20; 250():175-84. PubMed ID: 3423037
    [No Abstract] [Full Text] [Related]

  • 28. TCR V beta family repertoire and T cell activation markers in Kawasaki disease.
    Pietra BA, De Inocencio J, Giannini EH, Hirsch R.
    J Immunol; 1994 Aug 15; 153(4):1881-8. PubMed ID: 7913945
    [Abstract] [Full Text] [Related]

  • 29. Superantigens and their role in autoimmune disorders.
    Schiffenbauer J.
    Arch Immunol Ther Exp (Warsz); 1999 Aug 15; 47(1):17-24. PubMed ID: 11729824
    [Abstract] [Full Text] [Related]

  • 30. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy.
    Leucht S, Uttenreuther-Fischer MM, Gaedicke G, Fischer P.
    Clin Immunol; 2001 Apr 15; 99(1):18-29. PubMed ID: 11286538
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S, Yamano Y, Osame M, Hall WW.
    Cell Immunol; 1996 Nov 01; 173(2):312-6. PubMed ID: 8912892
    [Abstract] [Full Text] [Related]

  • 33. [Immunological studies on mucocutaneous lymphnode syndrome (Kawasaki disease). I. Plasma inhibitory factor(s) against blastic transformation of lymphocytes--a lack of plasma inhibitory factor(s) against blastic transformation of lymphocytes exposed to streptolysin O].
    Wakiguchi H, Kuramitsu M, Kitamura I.
    Arerugi; 1984 Nov 01; 33(11):978-84. PubMed ID: 6529371
    [No Abstract] [Full Text] [Related]

  • 34. Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease.
    Masuda K, Takei S, Nomura Y, Imanaka H, Sameshima K, Yoshinaga M.
    Pediatr Res; 1998 Jul 01; 44(1):27-31. PubMed ID: 9667366
    [Abstract] [Full Text] [Related]

  • 35. Streptococcal superantigens: categorization and clinical associations.
    Commons RJ, Smeesters PR, Proft T, Fraser JD, Robins-Browne R, Curtis N.
    Trends Mol Med; 2014 Jan 01; 20(1):48-62. PubMed ID: 24210845
    [Abstract] [Full Text] [Related]

  • 36. The role of T cells in Kawasaki disease.
    de Inocencio J, Hirsch R.
    Crit Rev Immunol; 1995 Jan 01; 15(3-4):349-57. PubMed ID: 8834455
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA, Shah V, Klein N, Dillon MJ.
    Arthritis Rheum; 2004 Feb 01; 50(2):589-97. PubMed ID: 14872503
    [Abstract] [Full Text] [Related]

  • 39. The etiology of Kawasaki disease: superantigen or conventional antigen?
    Rowley AH.
    Pediatr Infect Dis J; 1999 Jan 01; 18(1):69-70. PubMed ID: 9951986
    [No Abstract] [Full Text] [Related]

  • 40. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state.
    Ohga S, Ooshima A, Fukushige J, Ueda K.
    Eur J Pediatr; 1995 Jul 01; 154(7):539-41. PubMed ID: 7556319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.